US_PayorNews

Employers Look to PBMs for Lower Drug Costs and Better Access | iPharmaCenter

Badari Andukuri

Aug 15

Top 10 U.S. healthcare companies by 2026 revenue | iPharmaCenter

Badari Andukuri

Aug 5

UnitedHealth Scales Tennessee Health Hubs with $4M to Reach 200,000 Residents by 2027

Badari Andukuri

Jul 31

CMS Outlines Operational Path for 2028 Maximum Fair Price Compliance

Badari Andukuri

Jul 20

CMS Targets Fee-for-Service Fragmentation in New 2027 Policy Roadmap

Badari Andukuri

Jul 19

Aetna Survey Highlights Evolving Payer-Provider Confidence Landscape | iPharmaCenter

Badari Andukuri

Jul 15

CMS Proposes Major Medicare Overhaul: Shifting Toward Accountable Care and Value-Based Payments

Badari Andukuri

Jul 15

Navigating the Shift: Employer-Led Demands Reshape Pharmacy Benefit Management

Badari Andukuri

Jul 11

Optum Financial Adds Alegeus Platform To Deepen Consumer Health Benefits And Payments | iPharmaCenter

Badari Andukuri

Jul 6

CVS Pharmacy Joins Medicare GLP-1 Bridge and Scales Weight‑Loss Access Across the U.S. | iPharmaCenter

Badari Andukuri

Jun 27

Medicare GLP‑1 Bridge Program: Eligibility, Costs, and Drug Details | iPharmaCenter

Badari Andukuri

Jun 25

FDA Clears Sanofi’s Tzield as First Disease-Modifying Therapy for Stage 3 Type 1 Diabetes | iPharmaCenter

Badari Andukuri

Jun 17

CVS Caremark Shakes Up GLP-1 Coverage as Zepbound Returns to the Formulary | iPharmaCenter

Badari Andukuri

May 28

Most-Favored-Nation Drug Pricing: $733B in U.S. Savings? | iPharmaCenter

Badari Andukuri

May 21

UnitedHealthcare Reduces Prior Authorization Requirements by 30% and Standardizes Electronic Submissions | iPharmaCenter

Badari Andukuri

May 12

AHA Urges HRSA to Block Eli Lilly’s Expanded 340B Claims-Data Policy; Lilly Hits Back | iPharmaCenter

Badari Andukuri

Jan 31

CVS Health outlines strategy to streamline insurance and cut patient costs | iPharmaCenter

ipharmaservices

Jan 23

GSK, Novartis, Merck, Gilead, BMS and Amgen cut US drug prices for tariff relief and massive US investment

Badari Andukuri

Dec 22, 2025

FDA Clears Breyanzi as the First CAR T‑Cell Therapy for Relapsed or Refractory Marginal Zone Lymphoma in the US | iPharmaCenter

Badari Andukuri

Dec 5, 2025

Dual Special Needs Plans (D-SNPs) and Key 2026 Changes: What Dual Eligibles Need to Know During Medicare Enrollment | iPharmaCenter

ipharmaservices

Dec 2, 2025

Employers Look to PBMs for Lower Drug Costs and Better Access | iPharmaCenter

Top 10 U.S. healthcare companies by 2026 revenue | iPharmaCenter

UnitedHealth Scales Tennessee Health Hubs with $4M to Reach 200,000 Residents by 2027

CMS Outlines Operational Path for 2028 Maximum Fair Price Compliance

CMS Targets Fee-for-Service Fragmentation in New 2027 Policy Roadmap

Aetna Survey Highlights Evolving Payer-Provider Confidence Landscape | iPharmaCenter

CMS Proposes Major Medicare Overhaul: Shifting Toward Accountable Care and Value-Based Payments

Navigating the Shift: Employer-Led Demands Reshape Pharmacy Benefit Management

Optum Financial Adds Alegeus Platform To Deepen Consumer Health Benefits And Payments | iPharmaCenter

CVS Pharmacy Joins Medicare GLP-1 Bridge and Scales Weight‑Loss Access Across the U.S. | iPharmaCenter

Medicare GLP‑1 Bridge Program: Eligibility, Costs, and Drug Details | iPharmaCenter

FDA Clears Sanofi’s Tzield as First Disease-Modifying Therapy for Stage 3 Type 1 Diabetes | iPharmaCenter

CVS Caremark Shakes Up GLP-1 Coverage as Zepbound Returns to the Formulary | iPharmaCenter

Most-Favored-Nation Drug Pricing: $733B in U.S. Savings? | iPharmaCenter

UnitedHealthcare Reduces Prior Authorization Requirements by 30% and Standardizes Electronic Submissions | iPharmaCenter

AHA Urges HRSA to Block Eli Lilly’s Expanded 340B Claims-Data Policy; Lilly Hits Back | iPharmaCenter

CVS Health outlines strategy to streamline insurance and cut patient costs | iPharmaCenter

GSK, Novartis, Merck, Gilead, BMS and Amgen cut US drug prices for tariff relief and massive US investment

FDA Clears Breyanzi as the First CAR T‑Cell Therapy for Relapsed or Refractory Marginal Zone Lymphoma in the US | iPharmaCenter

Dual Special Needs Plans (D-SNPs) and Key 2026 Changes: What Dual Eligibles Need to Know During Medicare Enrollment | iPharmaCenter

Join our mailing list